SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-001445
Filing Date
2019-01-11
Accepted
2019-01-11 16:11:15
Documents
4
Group Members
CURT LABELLEPRIVATE MEDICAL EQUITY, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv510626_sc13da.htm SC 13D/A 103955
2 EXHIBIT 10.1 tv510626_ex10-1.htm EX-10.1 9414
3 EXHIBIT 10.2 tv510626_ex10-2.htm EX-10.2 9920
4 EXHIBIT 99.1 tv510626_ex99-1.htm EX-99.1 7083
  Complete submission text file 0001144204-19-001445.txt   131653
Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 19522449
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Filed by) CIK: 0001728916 (see all company filings)

Type: SC 13D/A